S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

CGEM Cullinan Therapeutics Inc

12.68

0.29 (2.34%)

After Hours

Last Updated: 15:04:07

Delayed by 15 minutes

Form ARS - Annual Report to Security Holders

Cullinan Therapeutics (NASDAQ:CGEM)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Cullinan Therapeutics Charts.

Cullinan Therapeutics (NASDAQ:CGEM)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Cullinan Therapeutics Charts.

Cullinan Therapeutics Inc News

Form 4 - Statement of changes in beneficial ownership of securities
Friday 20 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 20 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 20 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 16 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Thursday 14 November 2024 (2 months ago) • Edgar (US Regulatory)

Cullinan Therapeutics Announces Preclinical Data for CLN-978, a CD19-directed T Cell Engager, to be Presented at ACR Convergence 2024
Thursday 14 November 2024 (2 months ago) • GlobeNewswire Inc.

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Friday 8 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 7 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 7 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 7 November 2024 (2 months ago) • Edgar (US Regulatory)

Cullinan Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results
Thursday 7 November 2024 (2 months ago) • GlobeNewswire Inc.

Cullinan Therapeutics to Participate in Fireside Chat at Stifel 2024 Healthcare Conference
Tuesday 5 November 2024 (2 months ago) • GlobeNewswire Inc.

More Cullinan Therapeutics Inc News Articles

Fannie Mae (QB)

Tonix Pharmaceuticals

Bioelectronics (PK)

RespireRx Pharmaceuticals (CE)

Global Developments (PK)

Anavex Life Sciences

GBT Technologies (PK)

Lightwave Logic

Code Green Apparel (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions